NCT02500628View on ClinicalTrials.gov

Heart Rate Variability in Response to Metformin Challenge

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
FibromyalgiaMitochondrial DiseasesMovement DisordersDiabetes Mellitus, Type 2
Interventions
DRUG

Metformin

500 mg orally after baseline testing of heart rate

Trial Locations (1)

98072

Woodinville Psychiatric Associates, Woodinville

All Listed Sponsors
lead

Woodinville Psychiatric Associates

OTHER

NCT02500628 - Heart Rate Variability in Response to Metformin Challenge | Biotech Hunter | Biotech Hunter